Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob George

Showing results (791-800 of 849) with videos related to

Pageof 85
Sort By:
Hepatology (Baltimore, Md.)|December 10, 2017
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosisZobair M Younossi, Rohit Loomba, Quentin M Anstee, et al.
Journal of Hepatology|July 28, 2014
A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infectionAndrew J Muir, Sanjeev Arora, Gregory Everson, et al.
Journal of Hepatology|November 24, 2015
FibroGENE: A gene-based model for staging liver fibrosisMohammed Eslam, Ahmed M Hashem, Manuel Romero-Gomez, et al.
Nature Communications|March 6, 2015
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver diseaseMohammed Eslam, Ahmed M Hashem, Reynold Leung, et al.
Hepatology (Baltimore, Md.)|January 30, 2016
Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypesMohammed Eslam, Alessandra Mangia, Thomas Berg, et al.
Scientific Reports|February 7, 2019
A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanismsRasha El Sharkawy, Ali Bayoumi, Mayada Metwally, et al.
Plos Medicine|July 23, 2014
Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysisGiovanni Musso, Roberto Gambino, James H Tabibian, et al.
Gut|February 5, 2021
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?Ramy Younes, Olivier Govaere, Salvatore Petta, et al.
The Medical Journal of Australia|September 22, 2025
Clinical practice guidelines for hepatocellular carcinoma surveillance for people at high risk in Australia: summary of recommendationsJacob George, Nicole L Allard, Stuart K Roberts, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 6, 2021
A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver DiseaseZobair M Younossi, Janus P Ong, Hirokazu Takahashi, et al.
Pageof 85

Showing results (791-800 of 849) with videos related to

Sort By:
Pageof 85
Hepatology (Baltimore, Md.)|December 10, 2017
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosisZobair M Younossi, Rohit Loomba, Quentin M Anstee, et al.
Journal of Hepatology|July 28, 2014
A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infectionAndrew J Muir, Sanjeev Arora, Gregory Everson, et al.
Journal of Hepatology|November 24, 2015
FibroGENE: A gene-based model for staging liver fibrosisMohammed Eslam, Ahmed M Hashem, Manuel Romero-Gomez, et al.
Nature Communications|March 6, 2015
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver diseaseMohammed Eslam, Ahmed M Hashem, Reynold Leung, et al.
Hepatology (Baltimore, Md.)|January 30, 2016
Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypesMohammed Eslam, Alessandra Mangia, Thomas Berg, et al.
Scientific Reports|February 7, 2019
A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanismsRasha El Sharkawy, Ali Bayoumi, Mayada Metwally, et al.
Plos Medicine|July 23, 2014
Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysisGiovanni Musso, Roberto Gambino, James H Tabibian, et al.
Gut|February 5, 2021
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?Ramy Younes, Olivier Govaere, Salvatore Petta, et al.
The Medical Journal of Australia|September 22, 2025
Clinical practice guidelines for hepatocellular carcinoma surveillance for people at high risk in Australia: summary of recommendationsJacob George, Nicole L Allard, Stuart K Roberts, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 6, 2021
A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver DiseaseZobair M Younossi, Janus P Ong, Hirokazu Takahashi, et al.
Pageof 85